[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352598-105":59,"doc-detail-352598-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","eif3b-regulates-the-cell-cycle-of-lung-adenocarcinoma-cells-by-activating-the-gtse1-mediated-erkmapk-pathway-research-article","EIF3B regulates the cell cycle of lung adenocarcinoma cells by activating the GTSE1 mediated ERK/MAPK pathway - Research Article","","Objective explores the expression pattern, clinical significance, and molecular mechanism of EIF3B in lung adenocarcinoma (LUAD), aiming to support its potential as a diagnostic and prognostic biomarker and a therapeutic target. LUAD data from multiple databases are analyzed for correlations with clinical features and prognosis, while cell transfection and wound-healing assays, mouse subcutaneous tumor models, and Western blotting test EIF3B function and mechanism. Results indicate EIF3B promotes malignant behaviors via the GTSE1-ERK/MAPK axis.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/eif3b-regulates-the-cell-cycle-of-lung-adenocarcinoma-cells-by-activating-the-gtse1-mediated-erkmapk-pathway-research-article/352598/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/eif3b-regulates-the-cell-cycle-of-lung-adenocarcinoma-cells-by-activating-the-gtse1-mediated-erkmapk-pathway-research-article/352598.png","ImageObject",300,407,{"name":92,"@type":93},"Rhys","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main research objective of this study on EIF3B in LUAD?","Question",{"text":112,"@type":113},"The study aims to assess EIF3B’s expression pattern and clinical significance in LUAD, and to explore its potential molecular mechanism as a diagnostic/prognostic biomarker and therapeutic target.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were EIF3B functions and mechanism investigated in the study?",{"text":117,"@type":113},"LUAD data from multiple databases were analyzed for links between EIF3B expression, clinical characteristics, and prognosis, and experimental work combined cell assays (e.g., transfection and wound healing), mouse subcutaneous tumor models, and Western blotting.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the results show about EIF3B and tumor behavior?",{"text":121,"@type":113},"EIF3B was highly expressed in LUAD and associated with advanced stage and poor prognosis. EIF3B knockdown inhibited proliferation and migration, while overexpression promoted these processes, activating ERK/MAPK signaling through positively regulating GTSE1.",{"name":123,"@type":110,"acceptedAnswer":124},"What is the proposed biological pathway connecting EIF3B to LUAD progression?",{"text":125,"@type":113},"The study concludes EIF3B drives LUAD progression through an “EIF3B-GTSE1-ERK/MAPK-cell cycle” axis that influences cell-cycle proteins.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},352598,1790523115,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},687207024643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Xing et al. Respiratory Research (2026) 27:133 [https://doi.org/10.1186/s12931-026-03559-9](https://doi.org/10.1186/s12931-026-03559-9)  \nRespiratory Research  \nRESEARCH Open Access  \nEIF3B regulates the cell cycle of lung   \nadenocarcinoma cells by activating the GTSE1 mediated ERK/MAPK pathway  \nYingru Xing1,2,3†, Zhao Feng4†, Ying Zhang1, Jing Dai1, Zichao Bao1, Cheng Tao1, Jingjing Dai5* and Haizhou Wang3*  \nAbstract  \nObjective To preliminary explore the expression pattern, clinical significance, and potential molecular mechanism of EIF3B in lung adenocarcinoma (LUAD), and to provide preliminary evidence for its potential as a diagnostic and prognostic biomarker and therapeutic target (to be further verified by subsequent experiments) .  \nMethods LUAD data were obtained from multiple databases, and various statistical methods were used to analyze the correlation between EIF3B expression and clinical characteristics as well as prognosis. Cell experiments (transfection, wound healing, etc.), mouse subcutaneous tumor models, and Western blotting were combined to explore the function and mechanism of EIF3B.  \nResults EIF3B was highly expressed in LUAD tissues, which was associated with advanced staging and poor prognosis, with a diagnostic AUC value of 0.911. Knockdown of EIF3B inhibited the proliferation and migration of cancer cells, while overexpression promoted these processes. EIF3B activated the ERK/MAPK pathway by positively regulating GTSE1, thereby regulating cell cycle proteins. In mouse experiments, knockdown of EIF3B reduced tumor volume by approximately 60% and tumor weight by approximately 55% without affecting health.  \nConclusion EIF3B drives LUAD progression through the“EIF3B-GTSE1-ERK/MAPK-cell cycle” axis and has dual potential as a diagnostic and therapeutic target.  \nHighlights  \n1. High Expression of EIF3B Correlates with Poor Prognosis.  \n2. EIF3B Regulates Cell Cycle via GTSE1-ERK/MAPK Pathway.  \n3. EIF3B Knockdown Inhibits Tumor Growth.  \nKeywords Lung adenocarcinoma (LUAD), Eukaryotic initiation factor 3 subunit b (EIF3B), G2 and s phase expressed 1(GTSE1), Cell cycle, ERK/MAPK  \n†Yingru Xing and Zhao Feng are co-first authors.  \n*Correspondence: Jingjing Dai [hayydaijj@njmu.edu.cn](hayydaijj@njmu.edu.cn)[ ](hayydaijj@njmu.edu.cn)Haizhou Wang [wanghzpdph@126.com](wanghzpdph@126.com)  \n1School of Medicine, Anhui University of Science and Technology, Huainan 232001, China  \n2Key Laboratory of Industrial Dust Deep Reduction and Occupational Health and Safety of Anhui Higher Education Institutes, Huainan 232001, China  \n3Department of Blood Transfusion, Shanghai Pudong New Area People’s Hospital, Shanghai 201299, China  \n4Department of Breast and Thyroid Surgery, The First Affiliated Hospital, Anhui University of Science and Technology, Huainan 232001, China 5Department of Medical Laboratory, The Affiliated Huai’an NO.1 People’s Hospital of Naniing Medical University, Huaian, Jiangsu 223001, China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)","cbCaihIh4x9nqG1Q","https://ap.wps.com/l/cbCaihIh4x9nqG1Q","pdf",7823952,17,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Background: LUAD burden and diagnosis challenges\n## EIF3 complex and subunit roles in cancer\n# Main study rationale and early setup","[{\"question\":\"What is the main research objective of this study on EIF3B in LUAD?\",\"answer\":\"The study aims to assess EIF3B’s expression pattern and clinical significance in LUAD, and to explore its potential molecular mechanism as a diagnostic/prognostic biomarker and therapeutic target.\"},{\"question\":\"How were EIF3B functions and mechanism investigated in the study?\",\"answer\":\"LUAD data from multiple databases were analyzed for links between EIF3B expression, clinical characteristics, and prognosis, and experimental work combined cell assays (e.g., transfection and wound healing), mouse subcutaneous tumor models, and Western blotting.\"},{\"question\":\"What did the results show about EIF3B and tumor behavior?\",\"answer\":\"EIF3B was highly expressed in LUAD and associated with advanced stage and poor prognosis. EIF3B knockdown inhibited proliferation and migration, while overexpression promoted these processes, activating ERK/MAPK signaling through positively regulating GTSE1.\"},{\"question\":\"What is the proposed biological pathway connecting EIF3B to LUAD progression?\",\"answer\":\"The study concludes EIF3B drives LUAD progression through an “EIF3B-GTSE1-ERK/MAPK-cell cycle” axis that influences cell-cycle proteins.\"}]","EIF3B regulates the cell cycle of lung adenocarcinoma cells by activating the GTSE1 mediated ERK/MAPK pathway - Research Article | PDF",1790100402,43,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1933090a88e889430944aa24c76b1454.webp",983,1310,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b027b9768ae9644b1a0eb08f7e631a3c.webp",982,1309,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68dcef3a853030da69af55eca79732cf.webp",981,1308,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f801866f45971a394fbda2fe60ebf7a0.webp",980,1306]